1.42
-0.045(-3.08%)
Currency In USD
| Previous Close | 1.46 |
| Open | 1.74 |
| Day High | 1.64 |
| Day Low | 1.42 |
| 52-Week High | 2.12 |
| 52-Week Low | 0.86 |
| Volume | 6.04M |
| Average Volume | 277,075 |
| Market Cap | 32.4M |
| PE | -1.75 |
| EPS | -0.81 |
| Moving Average 50 Days | 1.3 |
| Moving Average 200 Days | 1.16 |
| Change | -0.05 |
If you invested $1000 in Femasys Inc. (FEMY) since IPO date, it would be worth $117.92 as of March 13, 2025 at a share price of $1.415. Whereas If you bought $1000 worth of Femasys Inc. (FEMY) shares 3 years ago, it would be worth $725.64 as of March 13, 2025 at a share price of $1.415.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
GlobeNewswire Inc.
5 hours ago
First-in-world approval of FemBloc delivery system for women seeking permanent birth controlATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's healt
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
GlobeNewswire Inc.
Feb 25, 2025 2:20 PM GMT
--Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both patients and practitioners-- ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a l
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
GlobeNewswire Inc.
Feb 11, 2025 2:00 PM GMT
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and IsraelATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant un